Latest Private Equity & Venture Capital News

A Middle East investment firm has committed $433 million to an Australian banking start-up.

Existing Australian technology could be used as a platform for COVID-19 self-tests.

Two Maori groups are in line for a substantial return on a direct private equity investment.

Funding from the Bill & Melinda Gates Foundation will bring a ground-breaking Australian vaccination technology closer to use for vaccinating children against measles.

The founders of a well-known retail chain have bought out their private equity investor.

A recently agreed private equity acquisition of a majority stake in an Australia-wide retail network is now in doubt.

A venture credit fund has provided $3 million to a data analytics company.

A Sydney private equity firm is expected to generate a return in excess of $500 million after exiting an investment to a major US firm.

Current uncertain times have not discouraged wholesale investors from investing in alternative credit, an investment firm has shown.

Private equity bidders are still in talks with an ASX-listed company despite its share price falling 76 per cent.

​​​​​​​Private capital is to be invested alongside government funding to provide $53 million to develop drugs to fight heart disease, high blood pressure and diabetes, some of the most common causes of premature death.

A Melbourne company which produces a mark-up tool for PDFs has attracted US venture capital.

Listed healthcare company rejects $2.1bn offer

Blackbird Ventures has invested $1 million in a start-up which has developed a medical device to relieve period pain.

A new manager has been appointed for the South Australian government’s $50 million venture capital fund.

By Margaret Schlott* The Australian private equity and venture capital industry is continuing to provide strong long-term performance for investors and is competitive with the private equity and venture capital industries of other developed countries, according to independent investment firm Cambridge Associates.

Kestrel Private Equity investee company Chant West Holdings Limited (ASX: CWL) has entered into an agreement to sell its superannuation research and consultancy business to Zenith Investment Partners for $12 million.